H-shares as a whole still trade at a discount of 32% to A-shares, compared with a low of 28% in March, according to the Hang ...

Shares of Jiangsu Hengrui Pharmaceuticals soared Friday morning, as more companies seek to tap Hong Kong’s capital markets.

Chinese pharmaceutical stocks got a boost from a strong debut of Jiangsu Hengrui Pharmaceuticals, the nation’s biggest drug ...

Shares of Chinese companies Jiangsu Hengrui Pharmaceuticals and Mirxes Holdings rose sharply on Friday in Hong Kong trading debuts after raising a combined $1.4 billion in separate listings.

The move appears to reflect the policy of the semiautonomous Chinese region to attract talent. Read more at straitstimes.com.

Theodore Shou, CEO of Yiyi Capital, discusses the recent strong performance of the IPO market in Hong Kong and says that the valuation premium between mainland China and Hong Kong stocks would narrow ...

Post’s #852 stories series secures third place in best new video or feature category during ceremony in New York.

HKUST has said it would welcome international students from Harvard after the US government moved to halt foreign enrolment ...

The newest Chinese hospital ship can provide "early-stage treatment and specialized care" during wartime to reduce combat losses.

The Chinese government criticizes the US's decision to ban international students from Harvard, highlighting the potential ...

Trump administration's latest ban on Harvard about enrolling foreign students has invited widespread criticism from China.

Qatar is Hong Kong's third-largest trading partner in the Middle East with bilateral trade in goods worth US$1.6 billion last ...